Shijiazhuang Yiling Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000015S0
CNY
18.08
0.38 (2.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,827.46
1,681.91
2,358.23
147.29
1,760.96
2,054.22
2,522.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,827.46
1,681.91
2,358.23
147.29
1,760.96
2,054.22
2,522.63
Raw Material Cost
678.86
600.03
1,140.98
323.14
865.15
979.07
1,280.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.36
0.26
0.14
0.54
8.43
10.49
9.55
Selling and Distribution Expenses
560.23
479.26
618.15
819.37
687.74
599.82
662.41
Other Expenses
18.54
18.62
15.61
24.94
16.55
19.31
16.20
Total Expenditure (Excl Depreciation)
1,424.82
1,265.74
1,915.35
1,392.49
1,726.84
1,782.51
2,113.95
Operating Profit (PBDIT) excl Other Income
402.59999999999997
416.2
442.9
-1245.2
34.1
271.70000000000005
408.7
Other Income
8.14
31.33
1.86
82.64
12.29
2.25
2.26
Operating Profit (PBDIT)
366.34
561.19
545.65
-1,275.42
181.73
421.96
514.62
Interest
0.36
0.26
0.14
0.54
8.43
10.49
9.55
Exceptional Items
0.00
0.00
0.00
-38.86
12.96
12.95
12.95
Gross Profit (PBDT)
1,148.60
1,081.88
1,217.25
-175.85
895.80
1,075.14
1,242.59
Depreciation
0.00
151.39
151.39
157.47
157.47
149.56
149.56
Profit Before Tax
365.98
409.54
394.12
-1,472.30
28.79
274.87
368.46
Tax
34.61
68.39
69.97
-189.03
6.33
50.16
66.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
331.87
342.58
325.95
-1,279.29
24.32
226.53
303.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
331.87
342.58
325.95
-1,279.29
24.32
226.53
303.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.49
-1.44
-1.80
-3.98
-1.86
-1.82
-2.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
331.38
341.14
324.16
-1,283.27
22.46
224.71
301.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
10,703.84
10,872.97
10,549.39
10,223.49
11,503.84
11,478.99
11,753.62
Earnings per share (EPS)
0.2
0.2
0.2
-0.77
0.01
0.14
0.18
Diluted Earnings per share
0.2
0.2
0.2
-0.77
0.01
0.14
0.18
Operating Profit Margin (Excl OI)
19.6%
22.5%
16.64%
-1028.92%
0.68%
13.15%
14.38%
Gross Profit Margin
20.03%
33.35%
23.13%
-892.66%
10.58%
20.66%
20.53%
PAT Margin
18.16%
20.37%
13.82%
-868.53%
1.38%
11.03%
12.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 8.66% vs -28.68% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -2.84% vs 5.21% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -32.40% vs -2.56% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 33.33% vs 200.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Shijiazhuang Yiling Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,827.46
0
1,827.46
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,827.46
0
1,827.46
Raw Material Cost
678.86
0
678.86
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.36
0
0.36
Selling and Distribution Expenses
560.23
0
560.23
Other Expenses
18.54
0.00
18.54
Total Expenditure (Excl Depreciation)
1,424.82
0
1,424.82
Operating Profit (PBDIT) excl Other Income
402.64
0.00
402.64
Other Income
8.14
0
8.14
Operating Profit (PBDIT)
366.34
0
366.34
Interest
0.36
0
0.36
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,148.60
0
1,148.60
Depreciation
0.00
0
0.00
Profit Before Tax
365.98
0
365.98
Tax
34.61
0
34.61
Provisions and contingencies
0
0
0.00
Profit After Tax
331.87
0
331.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
331.87
0
331.87
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.49
0
-0.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
331.38
0
331.38
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
10,703.84
0
10,703.84
Earnings per share (EPS)
0.20
0
0.20
Diluted Earnings per share
0.20
0
0.20
Operating Profit Margin (Excl OI)
19.60%
0%
0.00
19.60%
Gross Profit Margin
20.03%
0%
0.00
20.03%
PAT Margin
18.16%
0%
0.00
18.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 182.75 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.66% vs -28.68% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.78% vs -1.29% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 33.14 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -2.84% vs 5.21% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 1,372.89% vs -85.09% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.82 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -32.40% vs -2.56% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 111.45% vs -33.25% in Sep 2024

Quarterly - Interest
Interest 0.04 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 33.33% vs 200.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -95.24% vs -16.83% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.60%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024